Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hunan Wanlong Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, production, and sale of chemical drug preparations. Founded in 2002 and headquartered in Changsha, the company has built a diverse portfolio focusing on therapeutic areas such as gastroenterology, cardiovascular diseases, and anti-infectives. Its flagship products include Esomeprazole Sodium and Pantoprazole Sodium, which are widely used for treating acid-related gastrointestinal disorders. The company operates modern, GMP-compliant manufacturing facilities and maintains a robust R&D pipeline aimed at both generic improvements and innovative drug development. Wanlong is listed on China's National Equities Exchange and Quotations (NEEQ) and is recognized as a key high-tech enterprise in its region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wanlong Pharmaceutical.